Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Marijuana Advertising topic
No spam. Unsubscribe anytime.
Committee advances measure asking regulators to set advertising rules for low‑THC products, bar unproven medical claims
Summary
House Bill 342 directs the appropriate commission to promulgate rules governing advertising and marketing of low‑THC oil and related products, and bars medical claims not supported by reliable scientific evidence.
A committee member presented House Bill 342 as a short bill directing the commission (unspecified in the transcript) to promulgate rules and regulations to govern advertising and marketing of low‑THC oil and products. The presenter said the draft prohibits advertising that makes medical claims not supported by reliable scientific evidence and aims to prevent “snake oil” claims.
Committee members asked no substantive questions during the brief presentation. The bill was advanced by voice vote with no roll-call recorded.
The transcript indicates the measure directs the relevant regulatory commission to adopt advertising rules; the commission would determine the implementing rule language and enforcement mechanisms after enactment.
